BioBiggen
- Headquarters
- Beijing
- Business Model
- B2B
- Website
- biobiggen.com
- Last Round
- Venture RoundMay 2021
- Rounds
- 2
About
BioBiggen (Beijing Bohao Yuntian Technology Co., Ltd.) is a technology innovation enterprise co-founded by a senior management team with deep experience in the non-invasive prenatal testing market together with a team of internationally renowned medical geneticists, backed by several top-tier venture capital investors. The company positions itself as a global leader in non-invasive prenatal simultaneous screening technology for chromosomal and monogenic diseases, guided by a mission of serving public health.
Summary
BioBiggen is a Biotech company based in Beijing, China. Its most recent funding was a Venture Round in May 2021. Investors include Eight Roads Ventures, Lapam Capital and Lilly Asia Ventures.
Funding History
May 2021
Sign up to see all 2 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/biobiggen"><img src="https://indexed.vc/api/badge/company/biobiggen" alt="BioBiggen on Indexed.vc" width="260" height="76" /></a>
